EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines

Regina Hummel iD, Erika Dorochow iD, Sonja Zander, Katharina Ritter, Lisa Hahnefeld iD, Robert Gurke, Irmgard Tegeder iD, Michael K E Schäfer iD

Cells · 2024

DOI: 10.3390/cells13090734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Regina Hummel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University Medical Center Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Valproic Acid, Mice, Inbred C57BL, Neurons. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Women and Gender Equality Bureau (FGB), Mainz Research School of Translational Biomedicine (TransMed).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The histone deacetylase inhibitor (HDACi) valproic acid (VPA) has neuroprotective and anti-inflammatory effects in experimental traumatic brain injury (TBI), which have been partially attributed to the epigenetic disinhibition of the transcription repressor RE1-Silencing Transcription Factor/Neuron-Restrictive Silencer Factor (REST/NRSF). Additionally, VPA changes post-traumatic brain injury (TBI) brain metabolism to create a neuroprotective environment. To address the interconnection of neuroprotection, metabolism, inflammation and REST/NRSF after TBI, we subjected C57BL/6N mice to experimental TBI and intraperitoneal VPA administration or vehicle solution at 15 min, 1, 2, and 3 days post-injury (dpi). At 7 dpi, TBI-induced an up-regulation of REST/NRSF gene expression and HDACi function of VPA on histone H3 acetylation were confirmed. Neurological deficits, brain lesion size, blood–brain barrier permeability, or astrogliosis were not affected, and REST/NRSF target genes were only marginally influenced by VPA. However, VPA attenuated structural damage in the hippocampus, microgliosis and expression of the pro-inflammatory marker genes. Analyses of plasma lipidomic and polar metabolomic patterns revealed that VPA treatment increased lysophosphatidylcholines (LPCs), which were inversely associated with interleukin 1 beta (Il1b) and tumor necrosis factor (Tnf) gene expression in the brain. The results show that VPA has mild neuroprotective and anti-inflammatory effects likely originating from favorable systemic metabolic changes resulting in increased plasma LPCs that are known to be actively taken up by the brain and function as carriers for neuroprotective polyunsaturated fatty acids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticValproic AcidMice, Inbred C57BLNeuronsInflammationLysophosphatidylcholinesAnimalsMiceMaleCell DeathDisease Models, AnimalHistone Deacetylase InhibitorsNeuroprotective AgentsRepressor ProteinsRE1-Silencing Transcription Factor

Stichwörter der Autor:innen

lipidomic and metabolomic analyseslysophoshatidylcholineneuroinflammationthreonic acidtraumatic brain injuryvalproic acid

Substanzen

Valproic AcidLysophosphatidylcholinesHistone Deacetylase InhibitorsNeuroprotective AgentsRepressor ProteinsRE1-Silencing Transcription Factor

Autor:innen und Institutionen

  • Department of Anesthesiology, University Medical Center Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
  • Institute of Clinical Pharmacology, Medical Faculty, Goethe-University Frankfurt, 60596 Frankfurt am Main, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Fraunhofer Cluster of Excellence for Immune-Mediated Diseases, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
  • Focus Program Translational Neurosciences (FTN), Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
  • Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

ORCID-Profile: Regina Hummel, Erika Dorochow, Lisa Hahnefeld, Irmgard Tegeder, Michael K E Schäfer

Förderung

  • Deutsche Forschungsgemeinschaft
  • Women and Gender Equality Bureau (FGB)
  • Mainz Research School of Translational Biomedicine (TransMed)

Zitieren

APA

Hummel, R., Dorochow, E., Zander, S., Ritter, K., Hahnefeld, L., Gurke, R., Tegeder, I., & Schäfer, M. K. E. (2024). Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines. Cells. https://doi.org/10.3390/cells13090734

Vancouver

Hummel R, Dorochow E, Zander S, Ritter K, Hahnefeld L, Gurke R, et al. Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines. Cells. 2024. doi:10.3390/cells13090734

BibTeX
@article{Hummel2024,
  author = {Hummel, Regina and Dorochow, Erika and Zander, Sonja and Ritter, Katharina and Hahnefeld, Lisa and Gurke, Robert and Tegeder, Irmgard and Schäfer, Michael K E},
  title = {Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13090734}
}
Kostenlos starten →